摘要
背景:脑内出血(ICH)是中风的亚型,对人类造成高发病率和死亡率。 多项研究表明,神经炎症,兴奋性毒性,氧化应激,血栓降解产生的细胞毒性在ICH诱导的继发性脑损伤中起重要作用,有助于神经结局的恶化。 前列腺素E2(PGE2)是在这些进展中通常上调的前列腺素类,被证明通过在ICH后激活EP2受体来调节许多细胞和分子过程。 目的:本研究旨在探讨PGE2生物合成,EP2受体的下游信号通路和EP2受体在ICH诱导的脑损伤中的作用,旨在提供潜在的有效治疗策略。 方法:在PubMed,Medline和Ebase中搜索了大量关于EP2受体和脑内出血的文献。 结果:以前的研究表明,EP2受体通过激活不同的信号通路介导ICH中的双重作用。 EP2受体可以通过cAMP-PKA信号通路诱导神经保护,空间学习和神经可塑性,同时主要通过cAMP-Epac途径加强炎症反应。 此外,cAMP的浓度水平可能是决定哪个下游信号通路被激活的关键因素。 结论:在脑出血的不同阶段,EP2受体通过不同的下游信号通路在脑损伤中起多种作用。
关键词: 脑内出血,前列腺素E2,EP2受体,ICH引起的脑损伤。
图形摘要
Current Drug Targets
Title:The Double Roles of the Prostaglandin E2 EP2 Receptor in Intracerebral Hemorrhage
Volume: 18 Issue: 12
关键词: 脑内出血,前列腺素E2,EP2受体,ICH引起的脑损伤。
摘要: Background: Intracerebral hemorrhage (ICH), a subtype of stroke, brings high morbidity and mortality to human beings. Multiple studies indicated that neuroinflammation, excitotoxicity, oxidative stress, cytotoxicity resulted from the degradation products of blood clot play vital roles in ICH-induced secondary brain injury, which contributes to deterioration of neurological outcome. Prostaglandin E2 (PGE2), a type of prostanoids commonly up-regulated in these progresses, is proved to modulate numerous cellular and molecular processes by activating EP2 receptor after ICH.
Objective: This review aim to discuss the PGE2 biosynthesis, downstream signaling pathway of EP2 receptor and the roles of EP2 receptor in ICH-induced brain damage, targeting to provide a potential effective therapeutic strategy. Methods: A large number of literatures on EP2receptors and intracerebral hemorrhage were searched in PubMed, Medline, and Ebase. Results: Previous studies showed that EP2 receptor mediated double effects in ICH via activation of different signaling pathway. EP2 receptor could induce neuroprotection, spatial learning, and neuroplasticity via cAMP-PKA signaling pathway, while strengthen inflammation mainly through the cAMP-Epac pathway. In addition, the concentration level of cAMP might be the key factor that decides which downstream signaling pathway would be activated. Conclusion: In different phase of cerebral hemorrhage, EP2 receptor plays diverse effects in brain damage through different downstream signaling pathways.Export Options
About this article
Cite this article as:
The Double Roles of the Prostaglandin E2 EP2 Receptor in Intracerebral Hemorrhage, Current Drug Targets 2017; 18 (12) . https://dx.doi.org/10.2174/1389450117666151209122826
DOI https://dx.doi.org/10.2174/1389450117666151209122826 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Assays for Identification of Hsp90 Inhibitors and Biochemical Methods for Discriminating their Mechanism of Action
Current Topics in Medicinal Chemistry Heterocyclic Compounds as Anti-Inflammatory Agents
Current Bioactive Compounds Novel Approaches for Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Anesthetic and Adjunctive Drugs for Fast-Track Surgery
Current Drug Targets Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry Lipopolysaccharide-Induced Chorioamnionitis Causes Acute Inflammatory Changes in the Ovine Central Nervous System
CNS & Neurological Disorders - Drug Targets Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Dorsal Stream Dysfunction in Children. A Review and an Approach to Diagnosis and Management
Current Pediatric Reviews Mouse Models and the Role of Nitric Oxide in Reproduction
Current Pharmaceutical Design mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine
Current Medicinal Chemistry Why are Excipients Important to Neonates?
Current Pharmaceutical Design Clozapine Safety, 40 Years Later
Current Drug Safety Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
Current Neuropharmacology Ginsenoside RB1 Reduces Neurologic Damage, is Anti-Apoptotic, and Down-Regulates p53 and BAX in Subarachnoid Hemorrhage
Current Neurovascular Research Erratum:
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Current Drug Targets Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion
Current Neurovascular Research